Table 7.

Main Ongoing Trials of Cancer Vaccines Combined with ICIs

Trial	Cancer Type	Line of Treatment	Vaccine	Immunotherapy	Phase
NCT03380871	Non-squamous NSCLC	1	NEO-PV-01	Pembrolizumab + chemotherapy	I
NCT03647163	NSCLC	≥2	VSV-IFNβ-NIS	Pembrolizumab	I
NCT04266730	Squamous NSCLC, SCCHN	≥1	PANDA-VAC	Pembrolizumab	I
NCT03948763	NSCLC, CRC, Pancreatic Neoplasms	≥3	V941	Pembrolizumab	I
NCT03311334	Solid tumors	≥2	DSP-7888	Nivolumab	I/II
NCT02955290	NSCLC, SCCHN	≥2	CIMAvax	Nivolumab	I/II
NCT02879760	NSCLC	≥3	Ad-MAGEA3 and MG1-MAGEA3	Pembrolizumab	I/II
NCT02823990	Non-squamous NSCLC	≥2	TG4010	Nivolumab	II
NCT03353675	Non-squamous NSCLC	1	TG4010	Nivolumab + Chemotherapy	II

Abbreviations: CRC, colorectal cancer; SCCHN, squamous cell carcinoma of the head and neck.